bone morphogenetic proteins inhibit tumorigenic potential human brain tumour-initiating cells 
transformed oncogenic precursors possessing defining neural-stem-cell properties ability initiate intracerebral tumours identified human brain cancers1 report bone morphogenetic proteins bmps amongst bmp4 elicits strongest effect trigger significant reduction stem-like tumour-initiating precursors human glioblastomas gbms transient vitro exposure bmp4 abolishes capacity transplanted gbm cells establish intracerebral gbms importantly vivo delivery bmp4 effectively blocks tumour growth associated mortality occur % mice intracerebral grafting human gbm cells demonstrate bmps activate cognate receptors bmprs trigger smad signalling cascade cells isolated human glioblastomas gbms followed reduction proliferation increased expression markers neural differentiation effect cell viability concomitant reduction clonogenic ability size cd133+ population growth kinetics gbm cells indicates bmp4 reduces tumour-initiating cell pool gbms findings show bmp bmpr signalling system controls activity normal brain stem cells23 may also act key inhibitory regulator tumour-initiating stem-like cells gbms results also identify bmp4 novel non-cytotoxic therapeutic effector may used prevent growth recurrence gbms humans 
